Hyperinsulinemia and hyperglycaemia can enhance tumour cell proliferation by stimulating the phosphatidylinositol-3-kinase (PI3K) signalling cascade that stimulates the mammalian target of rapamycin (mTOR) through the protein kinase B (Akt) [4,5]. The gene discussed is AKT1; the disease is Hyperinsulinemia.